A novel ultra-high-performance supercritical fluid chromatography hyphenated to tandem mass spectrometry method for the analysis of urinary endogenous steroids in the anti-doping context.

Anti-doping analysis Athlete biological passport IRMS UHPSFC-MS/MS Urinary steroid profiling

Journal

Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488

Informations de publication

Date de publication:
08 Aug 2024
Historique:
received: 17 06 2024
revised: 30 07 2024
accepted: 31 07 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 27 8 2024
Statut: aheadofprint

Résumé

The first step in the detection of testosterone (T) doping is to measure the urinary steroid profile for the athlete biological passport (ABP). To harmonise the analysis between anti-doping laboratories, urinary steroid profiling is parametrised in deep detail and shall be performed by gas chromatography hyphenated to mass spectrometry (GC-MS). However, due to its requirement for extensive sample preparation, alternatives to GC-MS are being actively pursued. The aim of this study was the evaluation of Ultra-High-Performance Supercritical Fluid Chromatography hyphenated to tandem Mass Spectrometry (UHPSFC-MS/MS) as an alternative for the quantification of endogenous urinary steroids. In this context, we developed a high throughput sample extraction method, followed by a novel UHPSFC-MS/MS method for the analysis of 10 endogenous urinary steroids which are relevant for doping control analysis. Depending on the steroid, the herein presented method is capable of quantification from 0.5 ng/mL up to 10 µg/mL. After validation, the applicability of the method was evaluated by analysing 132 authentic urine samples, which demonstrated results similar to classical GC-MS analysis. Steroid concentrations determined by UHPSFC-MS/MS were slightly overestimated in comparison with GC-MS, but the ratios had <10 % difference between the two methods. As the ABP considers the steroid ratios for passport evaluation, the herein presented method could be used for steroid profiling without reducing the sensitivity of the ABP. Thus, we would propose to consider UHPSFC-MS/MS as an alternative to GC-MS after more tests would have been performed to support our findings. Furthermore, we have also investigated the potential of this technology for sample purification prior to Isotope Ratio Mass Spectrometry (IRMS) for the differentiation between exogenous and endogenous origin of T and its metabolites. While the achieved separation was sufficient to purify urine samples for IRMS analysis in our proof-of-concept study, the instrumental parameters should be further refined for future use.

Identifiants

pubmed: 39191183
pii: S0021-9673(24)00598-3
doi: 10.1016/j.chroma.2024.465224
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465224

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tobias Langer (T)

Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital and University of Lausanne, Switzerland; University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital, University of Geneva, Switzerland. Electronic address: tobias.langer@chuv.ch.

Raul Nicoli (R)

Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital and University of Lausanne, Switzerland.

Davy Guillarme (D)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland; School of Pharmaceutical Sciences, University of Geneva, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland.

Carine Schweizer-Grundisch (C)

Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital and University of Lausanne, Switzerland.

Serge Rudaz (S)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland; School of Pharmaceutical Sciences, University of Geneva, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland.

Silke Grabherr (S)

University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital, University of Geneva, Switzerland.

Tiia Kuuranne (T)

Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital and University of Lausanne, Switzerland.

Alessandro Musenga (A)

Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital and University of Lausanne, Switzerland.

Classifications MeSH